Viridien

06/10/21 -"EPS 2021 and 2022 are down, as we now expect an EBITDA of $325m vs $428m previously for 2021 and $480m vs $525m previously in 2022. We have revised our estimates based on the weak H1 and expect that ..."

PDF page sample
Pages
95
Language
English
Published on
06/10/21
Download
You may also be interested by these reports :
31/07/26
Fugro’s first half shows genuine operating progress: revenue and adjusted EBITDA both rise, and cost cuts flow through to a wider EBIT margin. ...
31/07/26
OMV delivered a materially stronger quarter vs Q1, driven by way higher refining margins, the first contribution from Borouge International and ...
31/07/26
Our FY26e earnings are cut to reflect the updated H1 2026 guidance: reported EBIT falls to €641m (from €707m) and net income to €225m (from €390m, ...
30/07/26
The quarter still bears the mark of the Middle East conflict on Sensing & Monitoring, though the underlying trend is improving. Revenue and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO